Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kubota CP1 and Atropine for Myopia
NCT06034379Recruiting
- Sponsor
- Kubota Vision
- Start
- Oct 2023
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Randomised, single-blind trial (3 arms), sponsored by Kubota Vision. Primary endpoints: Cycloplegic Spherical Equivalent Refraction at 12 months and Axial Length at 12 months. Started Oct 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06034379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06034379.